gb1211
Small moleculeexperimental
Clinical trial activity
7 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jan 14, 2019 (NCT03809052)
Timeline
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Liver Diseases · Phase 1/Phase 2
- Melanoma · Phase 2
- Multiple Myeloma · Phase 1
- Non-alcoholic Fatty Liver Disease · Phase 1/Phase 2
- Pharmacokinetics · Phase 1
- Pharmacological and Toxicological Phenomena · Phase 1
- Squamous Cell Carcinoma of Head and Neck · Phase 2
Mechanism of action
- Galectin-3INHIBITOR
LGALS3 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
OC[C@H]1O[C@H](Sc2cncc(Br)c2)[C@H](O)[C@@H](n2cc(-c3cc(F)c(F)c(F)c3)nn2)[C@H]1O- Mol. weight
- 533.33 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5182222 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07082270 | Phase 1 | Feb 1, 2026 | State University of New York, Buffalo |
| NCT05913388 | Phase 2 | Dec 31, 2023 | Galecto Biotech, Providence Health & Services |
| NCT05747573 | Phase 1 | Jan 3, 2023 | Galecto Biotech, QPS |
| NCT05240131 | Phase 1/Phase 2 (Phase 2) | Mar 15, 2022 | Galecto Biotech, Roche |
| NCT05009680 | Phase 1/Phase 2 (Phase 2) | Sep 9, 2021 | Comac Medical, Galecto Biotech |
| NCT04607655 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2021 | Covance, Galecto Biotech, University of Chicago |
| NCT03809052 | Phase 1 | Jan 14, 2019 | Covance, Galecto Biotech |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galecto Biotech | For profit | 6 | 5 | 2 | 2019 |
| Covance | For profit | 2 | 0 | 2 | 2019 |
| Comac Medical | For profit | 1 | 0 | 1 | 2021 |
| Providence Health & Services | Academic/Hospital | 1 | 1 | 1 | 2023 |
| QPS | For profit | 1 | 0 | 1 | 2023 |
| Roche | For profit | 1 | 0 | 1 | 2022 |
| State University of New York, Buffalo | Academic/Hospital | 1 | 1 | 1 | 2026 |
| University of Chicago | Academic/Hospital | 1 | 0 | 1 | 2021 |
8 organizations
Page 1 / 1